Eli Lilly and Co at JPMorgan Healthcare Conference Transcript
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting this fireside discussion with Dave Ricks, Chairman and CEO of Eli Lilly. Always a highlight of the conference for me.
Dave, Happy New Year. I know we're going to have some initial quick presentation, and we'll jump into the Q&A from there. So I'll it over to David.
Thank you, Chris. Great. Thank you, everyone, for being here to listen to us and Happy New Year to everyone. It's an important year for Lilly, it's our 150th year in existence, which I think makes us the most valuable old company in America.
So in addition to celebrating that, we have a lot to look forward to this year. I think last year at this conference, we were coming off a year where we were really sort of had our first full year of obesity launch with tirzepatide, and there were lots of unknowns and lots of uncertainties. And I think we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
